Periscope Capital’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACW
MF
SCM
CL
AA
PAMP
LP
LA
Periscope Capital's TDACW Position: Q1 2026 in Review
Periscope Capital increased its Translational Development Acquisition Corp Warrants (TDACW) stake by 25% in Q1 2026, buying an estimated $5.72K and bringing the position to 125,000 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #388.
Periscope Capital first reported a position in TDACW in Q1 2025 and has held it in 5 quarters since. The position peaked at $29.5K in Q4 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.
- Periscope Capital held 125,000 shares of Translational Development Acquisition Corp Warrants worth $17.5K as of Q1 2026.
- Periscope Capital bought 25,000 Translational Development Acquisition Corp Warrants shares in Q1 2026, an estimated $5.72K.
- Translational Development Acquisition Corp Warrants made up ﹤0.01% of Periscope Capital's portfolio in Q1 2026, its #388 holding.
- Periscope Capital first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 5 quarters since.
- Periscope Capital's Translational Development Acquisition Corp Warrants position peaked at $29.5K in Q4 2025.
- 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.
Based on Periscope Capital's 13F filing for Q1 2026, filed 14 May 2026.